CCHN ChemicalsChemical export sourcing from ChinaStart RFQ
Trade Policy & Compliance

【China Jiangs】CovationBio Completes Key Milestone at China Biomaterials Mega Facility & Launches Xatryx Brand

Source image preserved for article context.
Editor's note

Overseas buyers in polyurethane and specialty chemicals should note the H2 2026 operational target for CovationBio's 50,000-ton bioTHF and bioPTMEG capacity. The Xatryx brand signals a new renewable supply source, but regulatory alignment with China's circular economy policies and feedstock availability from agricultural by-products warrant close monitoring for supply-chain risk.

Covation Biomaterials (CovationBio) has achieved mechanical completion of its first commercial plant for the C4 product platform in Qidong, Jiangsu Province, China, and launched the Xatryx brand for its new bio-based PTMEG portfolio. The facility will produce bioTHF and bio-based polytetramethylene ether glycol (PTMEG), marking a major step in scaling renewable chemical production and offering overseas buyers a new source of sustainable intermediates for downstream applications.

Facility and investment overview

The C4 facility, built around CovationBio's proprietary process technology, represents a total investment of RMB 10 billion and is being developed in three phases. Once fully complete, it is expected to reach a total capacity of 500,000 tons per year of bio-based materials. Phase one, now mechanically complete, delivers 50,000 tons per year of commercial capacity for both bioTHF and bioPTMEG, with commercial production scheduled to begin in the second half of 2026.

Related source image

Xatryx brand and technology

Alongside the milestone, CovationBio officially launched the Xatryx brand, which will cover its new portfolio of non-food, bio-based PTMEG products manufactured at the site. The platform uses the company's Advanced ThermoChemical technology to convert abundant, non-food agricultural by-products directly into high-value chemical feedstocks, positioning Xatryx as a key material in next-generation sustainable manufacturing.

Targeting

What buyers should watch

Overseas importers and formulators in the polyurethane, elastomers, and specialty chemicals sectors should monitor the ramp-up of bioTHF and bioPTMEG supply from this facility. The 50,000-ton phase-one capacity, when operational in H2 2026, could offer a renewable alternative to fossil-based intermediates, potentially impacting sourcing strategies for sustainable product lines. Early engagement with CovationBio may provide supply security as the facility scales.

Digital Transformation In The Lab Delivering Efficiency & Sustainability

China sourcing context

The Qidong location in Jiangsu Province places the facility in a well-established chemical manufacturing hub with strong logistics links to major ports, facilitating export to global markets. The use of agricultural by-products as feedstock aligns with China's push for circular economy and bio-based industrial development, which may offer cost advantages and regulatory support for buyers seeking to diversify their supply chains with renewable chemicals.

Source: Read the original report | Published: June 11, 2026